Mental Health
From the Journals
Melatonin: A new way to reduce self-harm?
Melatonin may reduce the risk of self-harm by treating sleep problems related to psychiatric comorbidities, especially anxiety and depression.
From the Journals
Substance abuse disorders may share a common genetic signature
New findings could eventually lead to universal therapies to treat multiple and comorbid addictions, according to the study’s authors.
Behavioral Consult
Screen time and teenagers: Principles for parents
If screen time interferes with building independence, cultivating healthy social relationships, learning about their identity, managing their...
From the Journals
Cutting social media to 1 hour a day boosts self-image in young adults
Plenty of research has linked frequent social media use with body image issues and even eating disorders. But crucial gaps in our knowledge remain...
Opinion
Which recommendations on screening, diagnosing, and treating eating disorders are most helpful?
Recently, it has become more widely accepted that eating disorders may be found across people of a variety of socioeconomic statuses.
Latest News
Physician suicide: Investigating its prevalence and cause
“From your first day of medical school and throughout your career, there was a very rigid system in place that is quite unforgiving, is quite...
Livin' on the MDedge
The human-looking robot therapist will coach your well-being now
Plus: The mother of all mindsets and a colon named Collin.
Child Psychiatry Consult
LGBTQ+ teens in homophobic high schools
Comparing these two local high schools reinforced to me how visibility really matters in creating a childhood experience that is nurturing versus...
Commentary
Clinician violence: Virtual reality to the rescue?
Workplace violence is affecting so many providers in hospital emergency departments but also throughout other parts of the hospital.
From the Journals
Buprenorphine proves effective for fentanyl users in the ED
A new study provides additional information about emergency department buprenorphine as fentanyl becomes increasingly prevalent.
From the Journals
Once-daily stimulant for ADHD safe, effective at 1 year
Most treatment-emergent adverse events were mild to moderate,in a phase 3 study.